Zymedi

Manufacturing · South Korea · 11-50 Employees

View Company Info for Free

Overview

Headquarters

Posco Green Building Bldg 511 85 Songdok...

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Zymedi

Zymedi is dedicated to advancing precision medicine by discovering and developing innovative therapeutics for life-threatening diseases that lack effective treatment options. The company focuses on harnessing the noncatalytic regulatory functions of aminoacyl-tRNA synthetases (ARSs) as novel therapeutic targets to address significant unmet medical needs. With a robust pipeline of first-in-class drugs, Zymedi aims to redefine the understanding of diseases through the lens of ARS biology. They are open to partnerships with joint ventures, strategic investors, and in-licensing partners to further their mission.Explore more
Zymedi's Social MediaPopular SearchesZymediSIC Code 28,283NAICS Code 32,325Show more

Zymedi Org Chart

SK
South Korea flag for contact location.

Chief Executive Officer

PhoneEmail
OK
South Korea flag for contact location.

Chief Financial Officer

PhoneEmail
NK
South Korea flag for contact location.

Founder & Executive Vice President & Chief Te...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Zymedi your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Zymedi is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Zymedi is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Zymedi.

Zymedi Tech Stack

A closer look at the technologies used by Zymedi

Zymedi News & Media

Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding Zymedi

What is Zymedi's official website?
Zymedi's official website is www.zymedi.com
What is Zymedi's Revenue?
Zymedi's revenue is <$5 Million
What is Zymedi's SIC code?
Zymedi's SIC: 28,283
What is Zymedi's NAICS code?
Zymedi's NAICS: 32,325
How many employees does Zymedi have?
Zymedi has 11-50 employees
What industry does Zymedi belong to?
Zymedi is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What technology does Zymedi use?
Some of the popular technologies that Zymedi uses are: WordPress.org, PHP, Google Font API, YouTube
Who is the CFO of Zymedi?
Zymedi's CFO is Oliver Kim
Who is the CTO of Zymedi?
Zymedi's CTO is Nam Kwon
What does Zymedi do?

Zymedi is dedicated to advancing precision medicine by discovering and developing innovative therapeutics for life-threatening diseases that lack effective treatment options. The company focuses on harnessing the noncatalytic regulatory functions of aminoacyl-tRNA synthetases (ARSs) as novel therapeutic targets to address significant unmet medical... needs. With a robust pipeline of first-in-class drugs, Zymedi aims to redefine the understanding of diseases through the lens of ARS biology. They are open to partnerships with joint ventures, strategic investors, and in-licensing partners to further their mission.Read More

What are Zymedi social media links?
Zymedi Linkedin page
Is Zymedi a public company?
Zymedi is private company therefore does not currently have an official ticker symbol
See more information about Zymedi

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.